BLOODBORNE PATHOGENS CHECKLIST

29 CFR 1910.1030

The following checklist is based on 29 CFR 1910.1030. It covers the major aspects of the standard and good business practices and cannot be used to guarantee compliance with the standard. This checklist provides guidance in program implementation.

BLOODBORNE PATHOGENS CHECKLIST / YES / NO

I.Exposure Control

1.Has a written Exposure Control Plan been established? (c)(1)(i)
a.Is a copy of the Plan accessible to employees? (c)(1)(iii)
b.Procedure established to review and update the Plan:
1.As necessary to reflect new or modified tasks and procedures which affect occupational exposure? (c)(1)(iv)
2.As necessary to reflect new or revised employee positions with occupational exposure? (c)(1)(iv)
3.At least annually? (c)(1)(iv)
2.Does the written Plan address at least the following elements:
a.Exposure determination? (c)(1)(ii)(A)
b.Methods of compliance? (c)(1)(ii)(B)
c.HIV and HBV Research Laboratories and Production Facilities? (c)(1)(ii)(B)
d.Hepatitis B Vaccination and Post-Exposure Evaluation and Follow-up? (c)(1)(ii)(B)
e.Communication of Hazards to Employee? (c)(1)(ii)(B)
f.Recordkeeping? (c)(1)(ii)(B)
3.Has an Exposure Determination been conducted, without regard for the use of personal protective equipment? (c)(2)(i) & (c)(2)(ii)
4.Does the location have lists of the following:
a.Job classifications in which all employees have occupational exposure? (c)(2)(i)(A)
b.Job classifications in which some employees have occupational exposure? (c)(2)(i)(B)
c.Tasks and procedures in which occupational exposure occurs? (c)(2)(i) (C)
BLOODBORNE PATHOGENS CHECKLIST / YES / NO

II.Method of Compliance

1.Do methods of compliance specified in the Plan include the following:
a.Universal precautions to prevent contact with blood or other potentially infectious materials? (d)(1)
b.Engineering and work practice controls? (d)(2)
c.Personal protective equipment? (d)(3)
d.Housekeeping? (d)(4)

III.HIV and HBV Research Laboratories and Production Facilities

Questions 6 through 11 apply to Research Laboratories and Production Facilities engaged in the culture, production, experimentation and manipulation of HIV and HBV. They do not apply to clinical or diagnostic laboratories engaged solely in the analysis of blood tissues or organs.
1.Are procedures established for incinerating or decontaminating all regulated waste by a method, such as autoclaving, know to effectively destroy bloodborne pathogens? (e)(2)(i)
2.Are special practices established and documented in a Biosafety Manual? (e)(2)(ii)
3.Are certified biological safety cabinets or other combinations of personal protection or physical containment devices specified for use during activities involving other potentially infectious materials that pose an exposure threat via droplets, splashes, spills or aerosols?
4.Do HIV and HBV Research Laboratories contain:
a.Hand washing and eye washing facilities readily available within the work area? (e)(3)(i)
b.An autoclave available for decontamination of regulated waste? (e)(3)(ii)
5.Do HIV and HBV Production Facilities have established criteria for the following:
a.Separation from areas open to unrestricted traffic flow? (e)(4)(i)
b.Water resistant door, wall, floor and ceiling surfaces? (e)(4)(ii)
c.Sink for washing hands and readily available eye wash facility in each work area? (e)(4)(iii)
d.Self-closing access doors? (e)(4)(iv)
e.An autoclave for decontamination of regulated waste? (e)(4)(v)
f.A ducted exhaust air ventilation system? (e)(4)(vi)
6.Are employees in HIV and HBV Research Laboratories and Production Facilities required to receive additional initial training or demonstrate proficiency in practices and techniques prior to working with HIV or HBV including:
a.Standard microbiological practices and techniques? (g)(2)(ix)(A)
b.Practices and operations specific to the facility? (g)(2)(ix)(A)
c.Handling of human pathogens or tissue cultures? (g)(2)(ix)(B)

IV.Hepatitis B Vaccination and Post-Exposure Evaluation and Follow-Up

1.Are the hepatitis B vaccine and vaccination series made available to all employees who have occupational exposure? (f)(1)(i)
2.Are post-exposure evaluation and follow-up made available to all employees who have had an exposure incident? (f)(1)(i)
3.Are the medical evaluations and procedures (questions 12 & 13 above) required to be available to accordance with the following:
a.At no cost to the employee? (f)(1)(ii)(A)
b.At a reasonable time and place? (f)(1)(ii)(B)
c.Under the supervision of a licensed health care professional? (f)(1)(ii)(C)
d.In accordance with U.S. Public Health Service recommendations? (f)(1)(iii)
4.Are all laboratory test required to be conducted by an accredited laboratory at no cost to the employee? (f)(1)(iii)
5.Are there provisions for documentation of medical evaluations and procedures, including:
a.Routes of exposure and circumstances under which the exposure incident occurred? (f)(3)(ii)
b.Identification of the source individual, unless the employer can establish that identification is infeasible or prohibited by state or local law? (f)(3)(ii)
c.Consents for blood testing, unless consent cannot be legally obtained (f)(3)(ii)(A)
d.Information provided to the health care professional? (f)(4)
e.The health care professional's written opinion? (f)(5)

V.Communication of Hazards to Employees

1.Does the facility's program include communication of the hazards of bloodborne pathogens and other potentially infectious materials to all employees who may have occupational exposure? (g)
2.Do communication efforts include warning signs for work areas and labels for containers: (g)(1)(i)(ii)
3.Do warning signs and labels carry the BIOHAZARD legend? (g)(1)(i)(B),(g)(1)(ii)
4.Are warning signs and labels fluorescent orange-red, or predominantly so, with lettering or symbols in a contrasting color? (g)(1)(i)(C), (g)(1)(ii)(B)
5.Are employees with occupational exposure required to participate in a training program? (g)(2)(i)
6.Is training required as follows:
a.At the time of initial assignment to tasks with occupational exposure? (g)(2)(ii)(A)
b.At least annually thereafter? (g)(2)(ii)(B)(C)
7.Does the training contain, at a minimum, the following elements:
a.A copy of 1910.1030 and explanation of its contents? (g)(2)(vii)(A)
b.General explanation of epidemiology, symptoms and modes of transmission of bloodborne pathogens? (g)(2)(vii)(B)(C)
c.Explanation of the employer's control plan? (g)(2)(vii)(D)
d.Information on how to recognize hazards? (g)(2)(vii)(E)
e.Proper methods of control? (g)(2)(vii)(F-H)(M)
f.Information on the hepatitis B vaccine? (g)(2)(vii)(I)
g.Information on emergency procedures and post-exposure evaluation and follow-up? (g)(2)(vii)(J-L)
h.An opportunity for interactive questions and answers? (g)(2)(vii)(N)
8.Does the facility's program require additional training when changes, modifications, or addition of tasks affect the employee's occupational exposure? (g)(2)(v)

VI.Recordkeeping

1.Are requirements established for retention and access to employee medical records? (h)(1)(i)
2.Are training record requirements established and implemented, including:
a.Dates of training sessions? (h)(2)(I)(A)
b.Contents or summary of training sessions? (h)(2)(i)(B)
c.Names and qualifications of trainers? (h)(2)(i)(C)
d.Names and job titles of trainees? (h)(2)(i)(D)
e.Retention of records for 3 years? (h)(2)(ii)

09/20/02